“The present predicament has uncovered some structural weaknesses in the EU’s medicines source chain and a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She advisable that provide chain issues be addressed within an EU pharmaceutical tactic expected to ge